Medicenna Therapeutics Co...

NASDAQ: MDNA · Real-Time Price · USD
0.16
0.00 (1.91%)
At close: Jan 16, 2025, 9:00 PM

Medicenna Therapeutics Statistics

Share Statistics

Medicenna Therapeutics has 0 shares outstanding. The number of shares has increased by 0% in one year.

n/a
0%
0%
n/a
n/a
6,796
0.54%

Short Selling Information

n/a
n/a
n/a
n/a

Valuation Ratios

The PE ratio is 35.63 and the forward PE ratio is null. Medicenna Therapeutics's PEG ratio is -0.34.

35.63
n/a
0
n/a
1.87
-4.35
-0.34
Financial Ratio History

Enterprise Valuation

Medicenna Therapeutics has an Enterprise Value (EV) of 21.52M.

0
-1.32
-1.7
-1.7

Financial Position

The company has a current ratio of 9.57, with a Debt / Equity ratio of 0.

9.57
9.57
0
n/a
n/a
0

Financial Efficiency

Return on Equity is 5.25% and Return on Invested Capital is 7.69%.

5.25%
4.24%
7.69%
n/a
$96,687.5
16
0
n/a

Taxes

-11.6M
115.4%

Stock Price Statistics

The stock price has increased by -56.16% in the last 52 weeks. The beta is 0.77, so Medicenna Therapeutics's price volatility has been higher than the market average.

0.77
-56.16%
0.29
0.48
33.89
1,255,845

Income Statement

n/a
n/a
-16.3M
1.55M
-16.3M
-21.64M
0.02
Full Income Statement

Balance Sheet

The company has 33.6M in cash and 0 in debt, giving a net cash position of 33.6M.

33.6M
n/a
n/a
-80.98M
27.74M
23.99M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -12.66M and capital expenditures 0, giving a free cash flow of -12.66M.

-12.66M
n/a
-12.66M
-0.2
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

MDNA does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
2.81%
-22.96%
Dividend Details

Analyst Forecast

The average price target for MDNA is $2.5, which is 1462.5% higher than the current price. The consensus rating is "Buy".

$2.5
1462.5%
Buy
1
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

-4.13
1